Confusion Over Pricing Policy Escalates As India’s Supreme Court Slams Government For Delays
This article was originally published in PharmAsia News
Executive Summary
At the heart of the debate is how the Supreme Court interprets cost-based pricing or a market-based pricing system to ensure affordable drugs.